Arkolith/Insider Trading/EBS/Form 4

Dayal Sujata Tyagi

DirectorEmergent BioSolutions Inc. (EBS) · full profile →Form 4 · filed Nov 10, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$86K
Net Open-Market Flow
-$86K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 7, 2025Sell(S)9K$10.00$86K89K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001536908-25-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML